Healthcare provider profile · identity verified

Nathan Bolton

Family Practice · OLIVER SPRINGS, TN · NPI 1376170514

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	261	78
Levothyroxine Sodium	Levothyroxine Sodium	239	53
Lisinopril	Lisinopril	230	70
Omeprazole	Omeprazole	177	54
Amlodipine Besylate	Amlodipine Besylate	170	50
Gabapentin	Gabapentin	157	33
Albuterol Sulfate Hfa	Albuterol Sulfate	156	52
Ipratropium Bromide	Ipratropium Bromide	130	99
Fluticasone Propionate	Fluticasone Propionate	128	48
Pantoprazole Sodium	Pantoprazole Sodium	115	34
Tamsulosin Hcl	Tamsulosin Hcl	113	23
Losartan Potassium	Losartan Potassium	111	36
Famotidine	Famotidine	104	23
Doxycycline Hyclate	Doxycycline Hyclate	89	74
Rosuvastatin Calcium	Rosuvastatin Calcium	89	27
Metformin Hcl	Metformin Hcl	88	26
Metoprolol Succinate	Metoprolol Succinate	87	25
Hydrochlorothiazide	Hydrochlorothiazide	85	29
Metoprolol Tartrate	Metoprolol Tartrate	83	27
Mounjaro	Tirzepatide	83	17
Fluoxetine Hcl	Fluoxetine Hcl	82	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	79	18
Mupirocin	Mupirocin	77	49
Trazodone Hcl	Trazodone Hcl	76	19
Sertraline Hcl	Sertraline Hcl	72	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	27
Meloxicam	Meloxicam	71	20
Jardiance	Empagliflozin	70	16
Furosemide	Furosemide	69	19
Allopurinol	Allopurinol	68	11
Escitalopram Oxalate	Escitalopram Oxalate	67	17
Tizanidine Hcl	Tizanidine Hcl	66	19
Duloxetine Hcl	Duloxetine Hcl	61	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	59	52
Metformin Hcl Er	Metformin Hcl	55	17
Buspirone Hcl	Buspirone Hcl	52	16
Carvedilol	Carvedilol	51	25
Glimepiride	Glimepiride	50	12
Bumetanide	Bumetanide	46	13
Dicyclomine Hcl	Dicyclomine Hcl	46	suppressed
Eliquis	Apixaban	44	12
Ezetimibe	Ezetimibe	44	12
Montelukast Sodium	Montelukast Sodium	43	11
Quetiapine Fumarate	Quetiapine Fumarate	43	11
Ondansetron Odt	Ondansetron	41	17
Pravastatin Sodium	Pravastatin Sodium	41	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	13
Pregabalin	Pregabalin	40	12
Ibuprofen	Ibuprofen	38	11
Varenicline Tartrate	Varenicline Tartrate	38	12
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Testosterone Cypionate	Testosterone Cypionate	36	suppressed
Methylprednisolone	Methylprednisolone	35	28
Amitriptyline Hcl	Amitriptyline Hcl	34	11
Ozempic	Semaglutide	34	suppressed
Vascepa	Icosapent Ethyl	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Celecoxib	Celecoxib	30	12
Primidone	Primidone	30	suppressed
Cephalexin	Cephalexin	29	22
Donepezil Hcl	Donepezil Hcl	29	suppressed
Fluconazole	Fluconazole	29	18
Prednisone	Prednisone	29	24
Meclizine Hcl	Meclizine Hcl	28	12
Topiramate	Topiramate	28	11
Diclofenac Sodium	Diclofenac Sodium	27	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	24
Atenolol	Atenolol	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Simvastatin	Simvastatin	26	12
Tramadol Hcl	Tramadol Hcl	26	15
Cefdinir	Cefdinir	25	23
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	19
Fenofibrate	Fenofibrate	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Linzess	Linaclotide	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	17
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Ramipril	Ramipril	22	suppressed
Azithromycin	Azithromycin	21	15
Clonazepam	Clonazepam	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	18
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Nystatin	Nystatin	20	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	13
Finasteride	Finasteride	17	suppressed
Baclofen	Baclofen	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Promethazine Hcl	Promethazine Hcl	16	13
Sucralfate	Sucralfate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Torsemide	Torsemide	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Synjardy	Empagliflozin/Metformin Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Cimetidine	Cimetidine	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error